Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
In a Phase 3 obesity trial, patients on the highest dose of the weekly injectable, called survodutide, lost 13% of their weight after 76 weeks, compared with 5% in the placebo group, according to data presented Sunday at the annual meeting of the American Diabetes Association and published in the New England Journal of Medicine
Most prescribers recheck lipid panels at 1216 weeks after starting tirzepatide, then again at 2432 weeks to assess the full lipid response
Open Calculator Tirzepatide Statistics 2026 Explore the latest Zepbound and Mounjaro clinical data, sales statistics, and patient outcomes
Injections provide nearly 100% absorption, ensuring that the entire dose is available to support cellular functions
US$ 26.37
US$ 23.80
US$ 24.13
US$ 27.25
US$ 28.38
US$ 20.22
US$ 26.88
US$ 27.64
US$ 25.96
US$ 21.16
